Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05438329
Title First-in-human Study of DB-1305 for Advanced/Metastatic Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors DualityBio Inc.
Indications

triple-receptor negative breast cancer

lung small cell carcinoma

Her2-receptor negative breast cancer

lung non-small cell carcinoma

Advanced Solid Tumor

Therapies

DB-1305

Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST